2,4,6(1H,3H,5H)-Pyrimidinetrione,5-ethyl-5-(1-methyl-2-buten-1-yl)-

Suppliers

Names

[ CAS No. ]:
17013-35-3

[ Name ]:
2,4,6(1H,3H,5H)-Pyrimidinetrione,5-ethyl-5-(1-methyl-2-buten-1-yl)-

Chemical & Physical Properties

[ Density]:
1.106g/cm3

[ Molecular Formula ]:
C11H16N2O3

[ Molecular Weight ]:
224.25600

[ Exact Mass ]:
224.11600

[ PSA ]:
75.27000

[ LogP ]:
1.61860

[ Index of Refraction ]:
1.483

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
CQ5597500
CHEMICAL NAME :
Barbituric acid, 5-ethyl-5-(1-methyl-2-butenyl)-
CAS REGISTRY NUMBER :
17013-35-3
LAST UPDATED :
198910
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C11-H16-N2-O3
MOLECULAR WEIGHT :
224.29
WISWESSER LINE NOTATION :
T6VMVMV FHJ FY1&1U2 F2

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
20 mg/kg
TOXIC EFFECTS :
Brain and Coverings - recordings from specific areas of CNS Behavioral - convulsions or effect on seizure threshold Behavioral - excitement
REFERENCE :
JMPCAS Journal of Medicinal and Pharmaceutical Chemistry. (Washington, DC) V.1-5, 1959-62. For publisher information, see JMCMAR. Volume(issue)/page/year: 1,31,1959
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
3 mg/kg
TOXIC EFFECTS :
Brain and Coverings - recordings from specific areas of CNS Behavioral - convulsions or effect on seizure threshold Behavioral - excitement
REFERENCE :
JMPCAS Journal of Medicinal and Pharmaceutical Chemistry. (Washington, DC) V.1-5, 1959-62. For publisher information, see JMCMAR. Volume(issue)/page/year: 1,31,1959
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
21 mg/kg
TOXIC EFFECTS :
Brain and Coverings - recordings from specific areas of CNS Behavioral - convulsions or effect on seizure threshold Behavioral - excitement
REFERENCE :
JMPCAS Journal of Medicinal and Pharmaceutical Chemistry. (Washington, DC) V.1-5, 1959-62. For publisher information, see JMCMAR. Volume(issue)/page/year: 1,31,1959

Related Compounds

  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • [6-[(4,6-Dimethylpyrimidin-2-yl)sulfanylmethyl]-4-oxopyran-3-yl] 4-chloro-3-nitrobenzoate
  • N-(propan-2-yl)-1H-1,3-benzodiazol-2-amine
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • 6-isopentyl-4-(p-tolyl)-3,4,6,7-tetrahydro-1H-pyrrolo[3,4-d]pyrimidine-2,5-dione
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • (4-(4-Chlorophenyl)piperazin-1-yl)(5-(4-fluorophenyl)furan-2-yl)methanethione
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide